Alternatives to TrialJectory

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing a novel solution to treat lung cancer.

AI-driven clinical-grade breast cancer guide for women navigating their journey.

AI-powered platform for cancer diagnostics in digital pathology.

AI-powered IVF clinic solutions for digitization and automation.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.